| Product NDC: | 0006-4898 | 
| Proprietary Name: | COMVAX | 
| Non Proprietary Name: | Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine | 
| Active Ingredient(s): | 7.5; 5 ug/.5mL; ug/.5mL & nbsp; Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine | 
| Administration Route(s): | INTRAMUSCULAR | 
| Dosage Form(s): | INJECTION, SUSPENSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0006-4898 | 
| Labeler Name: | Merck Sharp & Dohme Corp. | 
| Product Type: | VACCINE | 
| FDA Application Number: | BLA103623 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 19961002 | 
| Package NDC: | 0006-4898-00 | 
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4898-00) > .5 mL in 1 VIAL, SINGLE-DOSE | 
| NDC Code | 0006-4898-00 | 
| Proprietary Name | COMVAX | 
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4898-00) > .5 mL in 1 VIAL, SINGLE-DOSE | 
| Product NDC | 0006-4898 | 
| Product Type Name | VACCINE | 
| Non Proprietary Name | Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine | 
| Dosage Form Name | INJECTION, SUSPENSION | 
| Route Name | INTRAMUSCULAR | 
| Start Marketing Date | 19961002 | 
| Marketing Category Name | BLA | 
| Labeler Name | Merck Sharp & Dohme Corp. | 
| Substance Name | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN; HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN | 
| Strength Number | 7.5; 5 | 
| Strength Unit | ug/.5mL; ug/.5mL | 
| Pharmaceutical Classes | Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |